Rodyti trumpą aprašą

dc.contributor.authorLiakina, Valentina
dc.date.accessioned2023-12-22T07:06:34Z
dc.date.available2023-12-22T07:06:34Z
dc.date.issued2023
dc.identifier.urihttps://etalpykla.vilniustech.lt/xmlui/handle/123456789/153730
dc.description.abstractRegardless of etiology, complications with bacterial infection in patients with cirrhosis are reported in the range of 25%-46% according to the most recent data. Due to frequent episodes of bacterial infection and repetitive antibiotic treatment, most often with broad-spectrum gram negative coverage, patients with cirrhosis are at increased risk of encountering multidrug resistant bacteria, and this raises concern. In such patients, extended-spectrum beta-lactamase and AmpC-producing Enterobacterales, methicillin- or vancomycin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, carbapenem-resistant Pseudomonas aeruginosa, and Acinetobacter baumannii, all of which are difficult to treat, are the most common. That is why novel approaches to the prophylaxis and treatment of bacterial infections to avoid antibiotic resistance have recently been developed. At the same time, our knowledge of resistance mechanisms is constantly updated. This review summarizes the current situation regarding the burden of antibiotic resistance, including the prevalence and mechanisms of intrinsic and acquired resistance in bacterial species that most frequently cause complications in patients with liver cirrhosis and recent developments on how to deal with multidrug resistant bacteria.eng
dc.formatPDF
dc.format.extentp. 7530-7542
dc.format.mediumtekstas / txt
dc.language.isoeng
dc.relation.isreferencedbyScience Citation Index Expanded (Web of Science)
dc.relation.isreferencedbyScopus
dc.rightsLaisvai prieinamas internete
dc.source.urihttps://talpykla.elaba.lt/elaba-fedora/objects/elaba:181299389/datastreams/MAIN/content
dc.titleAntibiotic resistance in patients with liver cirrhosis: Prevalence and current approach to tackle.
dc.typeStraipsnis Web of Science DB / Article in Web of Science DB
dcterms.licenseCreative Commons – Attribution – NonCommercial – 4.0 International
dcterms.references0
dc.type.pubtypeS1 - Straipsnis Web of Science DB / Web of Science DB article
dc.contributor.institutionVilniaus universitetas Vilniaus Gedimino technikos universitetas
dc.contributor.facultyFundamentinių mokslų fakultetas / Faculty of Fundamental Sciences
dc.subject.researchfieldN 004 - Biochemija / Biochemistry
dc.subject.researchfieldM 001 - Medicina / Medicine
dc.subject.enCirrhosis
dc.subject.enBacterial complications
dc.subject.enAntibiotics
dc.subject.enIntrinsic resistance
dc.subject.enAcquired resistance
dc.subject.enProbiotics
dc.subject.enVaccines
dcterms.sourcetitleWorld journal of clinical cases
dc.description.issueiss. 31
dc.description.volumevol. 11
dc.publisher.nameBaishideng Publishing Group Inc.
dc.publisher.cityPleasanton
dc.identifier.doi10.12998/wjcc.v11.i31.7530
dc.identifier.elaba181299389


Šio įrašo failai

Thumbnail

Šis įrašas yra šioje (-se) kolekcijoje (-ose)

Rodyti trumpą aprašą